Steen Riisgaard

Président chez Xellia Pharmaceuticals ApS

Profil

Steen Riisgaard currently works at Xellia Pharmaceuticals ApS, as Chairman, Villum Fonden, as Vice Chairman, New Xellia Group A, as Chairman, Novo Nordisk Fonden, as Director, and CAT Forsknings og Teknologipark A, as Director.
Mr. Riisgaard also formerly worked at Novozymes A, as President & Chief Executive Officer from 2000 to 2013, ROCKWOOL A, as Second Deputy Chairman in 2011, Egmont Fonden, as Chairman, ALK-Abello A, as Chairman from 2017 to 2020, Egmont International Holding A, as Chairman from 2014 to 2017, COWI A, as Chairman, World Wildlife Fund Denmark, as Chairman, Egmont Holding A, as Chairman-Supervisory Board, COWI Holding A, as Chairman from 2013 to 2021, Egmont (Denmark), as Chairman, Novo Holdings A, as Director from 2013 to 2018, the University of Aarhus, as Director, The European Association for Bioindustries, as Director, Novo Nordisk A, as Executive Vice President-Enzyme Business in 2000, Foss Electric Holding, as Research Microbiologist, Statens Serum Institute, as Principal, Corbion NV, as Independent Member-Supervisory Board from 2014 to 2026, and Novo Industri Japan Ltd., as Principal.
Mr. Riisgaard received his graduate degree in 1976 from the University of Copenhagen.

Postes actifs de Steen Riisgaard

Sociétés	Poste	Début
CAT Forsknings og Teknologipark A/S	Directeur/Membre du Conseil	-
Novo Nordisk Fonden	Directeur/Membre du Conseil	01/01/2013
Villum Fonden	Directeur/Membre du Conseil	-
Xellia Pharmaceuticals ApS	Président	-
New Xellia Group A/S	Président	-

Anciens postes connus de Steen Riisgaard

Sociétés	Poste	Fin
CORBION N.V.	Directeur/Membre du Conseil	13/05/2026
COWI Holding A/S	Président	01/04/2021
ALK-ABELLÓ A/S	Directeur Général	10/01/2017
Egmont International Holding A/S	Président	30/03/2017
░░░░░░░░░ ░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░